Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CEA Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch CEA in WB, IHC, FACS, IHC (p), ICC und IHC (fro). Er zeigt eine Reaktivität gegenüber Human und wurde in 3+ Publikationen erwähnt.
Produktnummer ABIN335404

Kurzübersicht für CEA Antikörper (ABIN335404)

Target

Alle CEA Antikörper anzeigen
CEA (Carcinoembryonic Antigen Gene Family (CEA))

Reaktivität

  • 179
  • 14
  • 5
  • 5
  • 1
Human

Wirt

  • 117
  • 77
  • 3
  • 1
  • 1
Maus

Klonalität

  • 148
  • 46
  • 4
Monoklonal

Konjugat

  • 78
  • 20
  • 14
  • 9
  • 6
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser CEA Antikörper ist unkonjugiert

Applikation

  • 94
  • 62
  • 49
  • 38
  • 30
  • 27
  • 24
  • 23
  • 20
  • 14
  • 13
  • 11
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))

Klon

PARLAM 4
  • Spezifität

    Human.

    Immunogen

    PARLAM 4 is a mouse monoclonal IgG1 antibody derived by fusion of Sp 2/0 Ag 14 mouse myeloma cells with spleen cells from a BABL/c mouse immunized with isolated human CEA. The immunogen has been isolated from human colonic carcinoma cells.

    Isotyp

    IgG1
  • Applikationshinweise

    Most polyclonal CEA antisera show cross-reactivity with related antigens such as biliary glycoprotein (BGP) and non-specific cross-reacting antigen 1/11 (NCA). PARLAM 4 does not show cross reactivity, neither with BGP nor with NCA. In immunoblotting the antibody recognizes a single band of 180 kD.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Lagerung

    4 °C
  • Taal, Hageman, Delemarre, Bonfrèr, den Hartog Jager: "Metastatic ovarian or colonic cancer: a clinical challenge." in: European journal of cancer (Oxford, England : 1990), Vol. 28, Issue 2-3, pp. 394-9, (1992) (PubMed).

    Henzen-Logmans, Schipper, Poels, Stolk, Kenemans, Meyer: "Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas." in: Journal of clinical pathology, Vol. 41, Issue 6, pp. 644-9, (1988) (PubMed).

    Verstijnen, Arends, Moerkerk, Warnaar, Hilgers, Bosman: "CEA-specificity of CEA-reactive monoclonal antibodies. Immunochemical and immunocytochemical studies." in: Anticancer research, Vol. 6, Issue 1, pp. 97-104, (1986) (PubMed).

  • Target

    CEA (Carcinoembryonic Antigen Gene Family (CEA))

    Andere Bezeichnung

    Carcinoembryonic Antigen / CEA

    Hintergrund

    This monoclonal antibody is reactive with human carcinoembryonic antigen (CEA), a tumour associated antigen with oncofetal characteristics. Although CEA can be found in tissues of non-neoplastic diseases and normal epithelia, it occurs also in a large variety of carcinomas. Therefore, immunohistochemical detection of CEA is frequently used for the histopathological diagnosis of human tumours.
Sie sind hier:
Chat with us!